Predictive value of immune inflammation index and systemic inflammation response index for contrast-induced acute kidney injury in endovascular treatment for acute ischemic stroke
Open Access
- 1 August 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (31) , e43642
Abstract
Endovascular treatment (EVT) is the treatment method for acute ischemic stroke (AIS) caused by large vessel occlusion. Contrast-induced acute kidney injury (CI-AKI) is a relatively common complication. In this study, we aimed to investigate the incidence and possible risk factors of CI-AKI including systemic inflammation response index (SIRI) and systemic immune inflammation index (SII) in patients undergoing mechanical thrombectomy. We retrospectively analyzed patients who underwent EVT for acute cerebral large vessel occlusion between January 1, 2021, and March 31, 2024. Before the intervention, blood was drawn from the antecubital vein and collected in the appropriate tubes. Serum levels of neutrophils, lymphocytes, platelets, hemoglobin, CRP, and albumin were measured, alongside lipid profiles and liver and kidney function parameters. An increase in serum creatinine of 0.5 mg/dL or more than 25% in the measurements 48 to 72 hours after EVT compared to before was defined as CI-AKI. SII was calculated with the formula of: peripheral (platelet count × neutrophil count)/ lymphocyte count; SIRI was calculated with the formula of: (neutrophil count × monocyte count)/ lymphocyte count. Their predictive value for CI-AKI occurrence was compared. CI-AKI was detected in 54 (19%) of the 281 patients included in the study. In terms of clinical parameters, baseline NIHSS, postthrombectomy, cerebral edema, hemorrhagic transformation, recanalization time, discharge mRS and contrast amount were significantly higher in patients with CI-AKI. SII exhibited the highest discriminative performance in predicting CI-AKI in patients undergoing mechanical thrombectomy, with a threshold of > 1784 (AUC = 0.710, 95% CI: 0.631–0.788, P < .001, sensitivity 42.6%, specificity 89.0%) followed by SIRI (AUC = 0.652, 95% CI: 0.576–0.728, P < .001, sensitivity 88.9%, specificity 37.9%). SII and SIRI were found to be significantly higher in patients with CI-AKI. These scores may be new promising low-grade inflammatory indicators for predicting CI-AKI development.Keywords
This publication has 33 references indexed in Scilit:
- Acute kidney injury after endovascular therapy in acute stroke patients: systematic review with meta-analysisJournal of NeuroInterventional Surgery, 2023
- Dynamic roles of neutrophils in post‐stroke neuroinflammationImmunology & Cell Biology, 2021
- The role of peripheral monocytes and macrophages in ischemic strokeNeurological Sciences, 2020
- Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery diseaseEuropean Journal of Clinical Investigation, 2020
- Contrast Induced Acute Kidney Injury and Direct Cytotoxicity of Iodinated Radiocontrast Media on Renal Proximal Tubule CellsThe Journal of Pharmacology and Experimental Therapeutics, 2019
- Functional Dynamics of Neutrophils After Ischemic StrokeTranslational Stroke Research, 2019
- Double-negative T cells remarkably promote neuroinflammation after ischemic strokeProceedings of the National Academy of Sciences, 2019
- Neutrophil, Lymphocyte, and Platelet Counts and Acute Kidney Injury After Cardiovascular SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2018
- Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trialThe Lancet, 2017
- Relation of Contrast-Induced Nephropathy to Long-Term Mortality After Percutaneous Coronary InterventionThe American Journal of Cardiology, 2014